Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
AMD claims the Ryzen 9000 CPUs are up to 8% faster than the previous Ryzen 9 7950X3D, with improvements in games like Black ...
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...
Nvidia (NVDA) and AMD (AMD) made headlines on Monday as each chipmaker unveiled their widely anticipated latest artificial ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power ...
HSBC just hit the brakes on the chipmaker, downgrading the stock from Buy to Reduce and slashing its price target from $200 to $110a move that signals a rocky road ahead. HSBC analyst Frank Lee didn't ...
AMD’s stock just got downgraded, with HSBC warning that the company’s “AI GPU roadmap is less competitive than we previously ...